Walmart (WMT) on Solana
Walmart Price Chart
Showing WMTx (highest volume)Walmart Variants on Solana
| Token | Issuer | Price | 24h Change | 24h Volume | Tokenized Value | Trades | |
|---|---|---|---|---|---|---|---|
WMTx
Walmart xStock
|
- | $108.66 | -8.24% | $13 | $14.4M | 1 | Trade WMTx |
|
W
WMTon
Walmart (Ondo Tokenize...
|
- | - | - | No trades yet | - | 0 | Trade WMTon |
About Walmart on Solana
Walmart is available on Solana through 2 bridged or wrapped variants. The most actively traded variant is WMTx (Walmart xStock).
Each variant represents the same underlying Walmart asset but is issued by a different bridge or protocol. When choosing which to trade, consider liquidity, volume, and the trust level of the issuing bridge.
Popular Walmart variants:
Walmart news, features & analysis
Matched on exact asset name, explicit ticker mentions, or associated variant token mints.
-
Walmart Fair Value Estimate Cut as Softer U.S. Comps Prompt Analyst Resets
Analysts trimmed their fair value estimates for Walmart (WMT) following the company's Q2 report, with consensus targets moving from roughly $138 to around $128. The primary trigger was U.S. comparable sales growth of 2.6%, which came in below expectations and raised questions about whether Walmart's elevated valuation multiple — modeled assumptions dropped from roughly 45.8x to 42.2x forward P/E — remains justified when same-store growth sits in the 2.5%–3.5% range. Deutsche Bank, Oppenheimer, and Gordon Haskett were among the skeptics flagging valuation sustainability, and shares fell in pre-market trading despite Walmart beating Q2 earnings estimates outright.
The bullish counter-argument centers on structural revenue diversification: e-commerce growth came in at 23–24%, and higher-margin streams such as advertising and Walmart+ memberships continued to scale. Management also cited a $3 billion tariff-refund reinvestment into pricing. Full-year guidance was raised to 4–5% net sales growth and 7–8.5% operating income growth, which some analysts argued warrants patience on the multiple. The disagreement reflects a broader debate about how much premium the market should assign a retailer with strong omnichannel momentum but softening core comp velocity.
-
Walmart Adding Google Pay and Apple Pay to US Store Checkout
Walmart is rolling out tap-to-pay support across its US stores, beginning August 24 at select Walmart and Sam's Club locations before expanding to all US stores by end of 2026, with gas stations to follow by mid-2027. Google Pay is confirmed through Alphabet, while Bloomberg has reported Apple Pay is also in the mix. "We want customers and members to have choice in how they pay, so they can check out in the way that works best for them," a Walmart spokesperson said.
The move marks a notable reversal for the retailer, which had long been one of the largest US holdouts on third-party contactless payment platforms, preferring to steer shoppers toward its own proprietary Walmart Pay app. Walmart Pay will continue to be offered alongside the new options, preserving its integrations with purchase tracking, digital receipts, and Walmart+ fuel savings. The checkout expansion follows recent operational announcements from Walmart, including an in-store automated fulfillment pilot, as the company broadens its retail technology footprint.
-
Walmart Posts Rare Comparable-Sales Miss as Consumer Spending Weakens
Walmart's fiscal second-quarter results blindsided investors on August 20, with U.S. comparable sales excluding fuel rising just 2.6% — well short of the 3.8% analyst consensus and the company's first comparable-sales miss in at least five years. The miss was broad-based: average spending per transaction grew only 1.1%, down from 3.1% a year earlier, while store traffic growth slowed to 1.5% from 3.0% in the prior quarter. The company's third-quarter adjusted EPS guidance of 62–64 cents also came in below the 68-cent street estimate, and net sales growth guidance of 3–3.75% underwhelmed, reinforcing what one analyst called "one of the biggest misses in years." Shares fell roughly 9%, erasing more than $80 billion in market value in Walmart's largest single-day decline since May 2022.
The result matters beyond Walmart's own balance sheet because the retailer had been the primary beneficiary of the consumer trade-down trade — budget-conscious shoppers shifting spending to its stores as inflation pressured household budgets. Brian Jacobsen, chief economic strategist at Annex Wealth Management, framed it starkly: "For the consumer economy, this is like Nvidia posting a slowdown. Walmart has been winning the trade-down trade, but that tailwind may be fading." Gasoline prices above $4 per gallon are now pressuring even Walmart's core shoppers, with the company guiding for $2 billion in incremental fuel costs above its original forecast. The below-consensus Q3 outlook signals management expects the spending squeeze to persist through the second half of 2026.
-
Walmart Begins First In-Store Automated Fulfillment Pilot
Walmart has launched its first in-store automated fulfillment pilot, deploying Symbotic's SymMicro micro-fulfillment system inside an existing store location. The initiative tests whether automation can reduce e-commerce fulfillment costs and cut congestion from in-store order picking, using Walmart's broad retail footprint as a network of embedded fulfillment hubs rather than separate warehouse facilities.
The pilot is a direct bid to improve unit economics on Walmart's growing online business. By automating last-mile pick-and-pack operations within stores, the company aims to lift profit margins on e-commerce orders — a segment that has historically weighed on retail profitability. Investors will be watching upcoming earnings disclosures for early signals on whether the SymMicro rollout moves the needle on fulfillment cost per order and supply chain efficiency.
-
Walmart Launches Family-Focused Exclusives as Aug. 20 Earnings Countdown Begins
Walmart is scheduled to report earnings on August 20, 2026, with investors watching closely for commentary on cost management, guidance, and how growth in e-commerce and higher-margin services is holding up against pressure on lower-income shoppers. Community analysts have placed fair value estimates for WMT shares between $93.94 and $154.58, with some flagging that the stock may be overextended by roughly 23% — making margin and guidance updates particularly consequential for near-term price action.
Ahead of the report, Walmart has rolled out a set of family-focused exclusive product lines spanning health, safety, and food categories, including Kanoodle games, Bliss Baby skincare, Nurture Life kids' meals, Tru Niagen supplements, and Guardian Tech safety products. The company is positioning itself as a scaled omnichannel platform for brands, using Walmart.com alongside physical stores to broaden its appeal to family shoppers. Analysts characterize the new launches as reinforcing Walmart's existing strategy rather than representing a material standalone financial catalyst.
-
What Walmart's Fed Data Role Means for Its Pricing Power
Former Walmart CEO Doug McMillon has joined a Federal Reserve task force examining real-time retail data and AI, putting the company at the center of US economic policy discussions. The appointment is seen as a validation of Walmart's expanding data and analytics capabilities, but analysts note the elevated political visibility may come with a constraint: pricing scrutiny from Washington could limit the retailer's ability to pass cost increases on to consumers compared to less-visible competitors like Amazon or Target.
Rather than relying on traditional price-lever management, Walmart may need to increasingly monetize its scale through higher-margin businesses — advertising via Walmart Connect, membership fees from Walmart+, and proprietary transaction data — to sustain profitability. International e-commerce and logistics costs remain unresolved headwinds, but the Fed role underscores that Walmart's data assets are now viewed as a distinct strategic profit driver, not merely a retail operational byproduct.
-
Walmart Faces Bull and Bear Debate Ahead of Aug. 20 Earnings Report
Walmart's August 20 earnings report is drawing attention from investors weighing the retailer's standout digital momentum against an elevated valuation. The clearest bull argument centers on e-commerce: global online sales surged 26% year over year in the most recent quarter, with membership fees up 17%, a trajectory that increasingly resembles Costco's high-margin membership model. That performance has come alongside consistent revenue and operating income growth — revenue rose 7.3% and operating income 5% last quarter — and a track record of roughly 17% average annual share gains over the past decade.
The bear case is almost entirely about price. Walmart's forward P/E has climbed to approximately 38, well above its five-year average of 27, and its price-to-sales ratio of 1.24 sits roughly 50% above its five-year average of 0.83. That premium leaves little room for disappointment, and analysts who see the valuation as stretched — including Oppenheimer, which downgraded shares earlier this month — argue the stock is pricing in near-flawless execution heading into the print. Investors will be watching whether e-commerce growth rates hold and whether membership-fee revenue continues to scale as the key metrics that justify the current multiple.
-
Walmart Ties GLP-1 Strategy to Customer Retention via Better Care Services and LillyDirect
Walmart is layering GLP-1 services into its retail footprint through two programs: its Better Care Services platform, which connects pharmacy customers to third-party providers for weight management support for those on or exploring GLP-1 therapies, and a partnership with Eli Lilly that brings LillyDirect's direct-to-consumer pricing for Zepbound (tirzepatide) to Walmart's roughly 4,600 pharmacies nationwide. LillyDirect's pricing offers a 50% or greater discount compared to list prices for other GLP-1 obesity medicines, positioning Walmart as a lower-cost pickup point for the drug.
The customer retention logic is straightforward: monthly prescription pickups create recurring store visits, and GLP-1 patients browsing Walmart's aisles are seen as buyers for high-margin adjacent categories such as protein supplements, vitamins, and fitness-related consumables — helping offset the reduced grocery spend that tends to accompany GLP-1 use. For Walmart, the pharmacy is increasingly a foot-traffic engine rather than a standalone business line.
-
Oppenheimer Downgrades Walmart as Stretched Valuation Limits Near-Term Upside
Oppenheimer analyst Rupesh Parikh downgraded Walmart to Perform from Outperform and removed his $140 price target, citing a less attractive risk/reward setup ahead of the retailer's August 20 earnings report. The move makes Oppenheimer one of only four analysts out of 44 covering the stock without a buy-equivalent rating — a concentration of bullishness that Parikh argues already prices in substantial confidence, leaving little room for shares to surprise to the upside.
Three headwinds drive the call. First, Walmart faces potential pharmacy-related drag on U.S. comparable-sales growth tied to Inflation Reduction Act-linked pricing changes that could weigh on wellness revenue. Second, the stock's valuation looks stretched: shares trade at roughly 36 times next-twelve-months earnings versus a historical average near 23x (the April 2026 peak reached 44x). Third, consensus estimates already sit "well ahead" of management's own longer-term guidance, meaning the Street is underwriting an outperformance scenario that leaves the stock exposed to a multiple compression if comp growth decelerates. Oppenheimer's own Q2 U.S. comp estimate of 3% trails the Street at 3.8%, reflecting continued grocery strength but moderating momentum in general merchandise and health categories.
Despite stepping to the sidelines, Parikh remains constructive on Walmart's long-term franchise and management team. The downgrade is a near-term tactical call — not a change in the fundamental thesis — positioning investors for a more attractive entry point once valuation and expectations reset around the earnings print.
-
Walmart's 4,600-Pharmacy Network Positions It as a Leading GLP-1 Direct-Prescription Beneficiary
Walmart became the first traditional retailer to serve as a pickup option for LillyDirect's direct-to-consumer Zepbound program in November 2025, offering patients $349/month for 2.5mg vials and $499/month for higher doses — the lowest retail pickup price for Zepbound among major chains. Its network of more than 4,600 pharmacies supports same-day pickup or one-hour home delivery (free for Walmart+ members), giving it a structural scale advantage as employer GLP-1 coverage shrinks and more Americans shift to self-pay direct programs.
In April 2026, Walmart expanded its positioning with the launch of "Better Care Services," a virtual care marketplace connecting customers to five telehealth providers whose e-prescriptions route directly into Walmart's pharmacy fulfillment system. Analysts covering the GLP-1 market view Walmart's combination of low-cost pickup pricing and broad physical footprint as a durable customer acquisition mechanism: each monthly GLP-1 refill is a recurring touchpoint that draws patients into a store ecosystem and creates the potential for extended multi-year retail relationships beyond the prescription itself.
Trade Walmart
Trade Activity (All Variants)
Quick Links
Solana Token Markets